The Bioprocess International Conference & Exhibition is one of the world’s largest bioprocessing events bringing together the science, technologies and partners needed to accelerate promising biologics towards commercial success during the biotech week in Boston.

Less than 3 miles apart, the CAR-TCR Summit is the only dedicated, end-to-end summit focused on accelerating to market the next generation of potent, safe and efficacious CAR-TCR therapies for solid tumor indications, whilst ensuring the accessibility and commercial delivery of currently approved life-changing CAR-TCR therapies to patients around the world.

We will be playing an active role in both meetings, as sponsors, exhibitors and presenters.

Bioprocess International Conference & Exhibition
 

Implementation of BPOG’s Biomanufacturing Technology Roadmap: Progress, Challenges and Prospects

Pre-conference symposium #5: Process intensification
September 4, 2018 | 4:00 pm
Round table panelist: Rajesh Beri, Ph.D., Technical Director, Research & Technology, Lonza Pharma & Biotech

Over 30 organizations representing Biomanufacturers, Technology suppliers and Academic institutions participated in developing a first of its kind Technology Roadmap for Biologics Manufacturing. The BPOG TRM published in July 2017 has generated considerable interest within the Industry. Over 100 critical needs were identified by the six Roadmap sub teams to achieve the 10-year vision of lower Cost of Goods, increased quality and speed and increasing diversity of facility design. 12 key projects addressing the respective critical needs were initiated in October 2017 by the participating organizations. At the conclusion of year 1, the progress made as well as retrospective inspection of the Tech Roadmap effort and future prospects will be reviewed during this presentation.

Join us in booth #1301 to learn more about our bioprocessing services from development through manufacturing including a demonstration of the MAST™ System for automated sampling. 


CAR-TCR Summit
 

End-to-end Manufacturing Platforms for Patient-Scale Cell Therapies: CocoonTM Systems

Summit day #2, CAR-TCR Manufacturing Track
September 6, 2018 | 1:10 pm
Co-presentation by Yaling Shi, Senior Research & Development Manager at Lonza Pharma & Biotech and Nuala Trainor, Director of Biological Programs at Octane.

This presentation aims to highlight the key needs and challenges facing this industry, such as robustness, efficiency and scalability and present the capabilities and features of the CocoonTM system as an advanced autologous cell therapy manufacturing platform. A case study will be presented using the the CocoonTM system to translate a labor-intensive CAR-T process into this fully automated system, thus allowing scalability, high yielf, reduction of manufacturing cost and better process control to yield high-quality CAR-T cells.

The CocoonTM system will also be available for demonstrations at our Lonza booth #52 in the exhibition area throughout the duration of the congress. We look forward to seeing you there.

Rajesh_Beri.jpg

Rajesh Beri, Ph.D., Technical Director, Research & Technology, Lonza Pharma & Biotech

 

 

 

 

 

 

Yaling_Shi.jpg

Yaling Shi, Senior Research & Development Manager, Lonza Pharma & Biotech

Nuala Trainor (Octane) - Headshot.jpg

Nuala Trainor, Director of Biological Programs, Octane

Use the form below to organize a meeting in advance with one of our representative in Boston during the CAR-T summit and Biotech week. We look forward to seeing you there!

 

By submitting your data through this form, you confirm that you are above the age of 18, that you have read and understood the Privacy Policy, and that you agree to the collection, use and processing of your Personal Information by Lonza in accordance with said policy.